Biomea Fusion BMEA
NASDAQ BMEA
$1.75 +0.04 (+2.63%)
As of: Sep 22, 2026 · 11:12 AM EDT

Biomea Fusion (BMEA) Capital Expenditures (2020 - 2025)

Biomea Fusion's (BMEA) quarterly Capital Expenditures came in at -$619000.0 in Q4 2025, up 88.01% year-over-year from -$329232.3 in Q4 2024, and up 88.01% quarter-over-quarter from -$5.2 million in Q4 2024.

Analysis

Biomea Fusion (BMEA) Capital Expenditures (2020 - 2025) Analysis & Trends

Biomea Fusion has disclosed Capital Expenditures across 6 years of filings, most recently posting -$619000.0 for Q4 2025.

  • In Q4 2025, Capital Expenditures rose 88.01% year-over-year to -$619000.0; the TTM figure through Dec 2025 stood at -$619000.0 (up 87.33% YoY), while the FY2025 annual figure was -$619000.0, up 87.33% from the prior year.
  • Capital Expenditures came in at -$619000.0 for Q4 2025 at Biomea Fusion, up from -$5.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $2.9 million in Q1 2023 to a low of -$5.2 million in Q4 2024.
  • Average Capital Expenditures over 5 years is $121647.1, with a median of $95000.0 recorded in 2022.
  • Year-over-year, Capital Expenditures surged 2958.95% in 2023 and slumped 64650.0% in 2024.
  • Over 5 years, Capital Expenditures stood at $293000.0 in 2021, then surged by 143.0% to $712000.0 in 2022, then slumped by 98.88% to $8000.0 in 2023, then tumbled by 64650.0% to -$5.2 million in 2024, then surged by 88.01% to -$619000.0 in 2025.
  • Per Business Quant data, the three most recent Capital Expenditures figures were -$619000.0 in Q4 2025, -$5.2 million in Q4 2024, and $186000.0 in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 1.32 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 322.00 Mn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -321.00 Mn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 533.00 Mn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 305.00 Mn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - 2.29 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 25.02 Mn
10 Biomea Fusion 132.65 Mn 132.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -619,000.00
Dec 31, 2024 -5.16 Mn
Sep 30, 2024 186,000.00
Jun 30, 2024 59,000.00
Mar 31, 2024 35,000.00
Dec 31, 2023 8,000.00
Sep 30, 2023 39,000.00
Jun 30, 2023 417,000.00
Mar 31, 2023 2.91 Mn
Dec 31, 2022 712,000.00
Sep 30, 2022 -50,000.00
Jun 30, 2022 273,000.00
Mar 31, 2022 95,000.00
Dec 31, 2021 293,000.00
Sep 30, 2021 2.04 Mn
Jun 30, 2021 771,000.00
Mar 31, 2021 67,000.00
Dec 31, 2020 39,000.00
API Access

Biomea Fusion Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BMEA&period=max&api_key=YOUR_API_KEY